Product category:
Lab automation equipment and robotics
News Release from: Tecan (UK) | Subject: LabCD
Edited by the Laboratorytalk Editorial
Team on 18 October 2002
Technical posters illustrate
microfluidics
Two new technical posters describe applications performed with proprietary microfluidic technology that combines microscale fluid paths, reaction chambers, and passive valves
Tecan (UK) has announced the free availability of copies of two new technical posters describing applications performed on its innovative LabCD system recently launched at the Drug Discovery Technology 2002 conference (Boston, USA) Developed in conjunction with five major pharmaceutical companies, the LabCD system benefits from proprietary microfluidic technology that combines microscale fluid paths, reaction chambers, and passive valves
This article was originally published on Laboratorytalk on 22 Oct 2004 at 8.00am (UK)
Related stories
Microfluidic assay on a CD
Part of a fully integrated and validated system that performs all fluid-related functions thus guaranteeing assay reliablity and consistency from one location and one assay to the next
Centrifugally driven microfluidics platform
Combines microscale fluid paths, reaction chambers, and passive valves on a disposable compact disc operating on one easy-to-use automated platform
The result is major reductions in the time and cost of drug development by allowing researchers to obtain critical information much earlier in the drug discovery process.
The first poster describes a seamless fully integrated method for undertaking fluorescence based Cytochrome P450 assays on the LabCD system.
Illustrated with results from a series of Admet applications Tecan's LabCD approach enables greater than ten-fold reductions in reagent usage while limiting non-specific binding issues.
The second poster describes how the Tecan LabCD system in conjunction with Genesis liquid handling workstation and Ultra microplate reader provides a fully automated method using drug displacement of fluorescent dyes specific for three binding sites on serum proteins.
The poster illustrates the simultaneous and rapid determination of the apparent affinities of two compounds for three sites of human serum proteins.
The developed protocol offers push button output of reproducible binding affinities with less time and labour than traditional methods.
• Tecan (UK): contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
